BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30706375)

  • 1. Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.
    Swords DS; Skarda DE; Sause WT; Gawlick U; Cannon GM; Lewis MA; Scaife CL; Gygi JA; Tae Kim H
    J Gastrointest Surg; 2019 Apr; 23(4):659-669. PubMed ID: 30706375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.
    Swords DS; Brooke BS; Skarda DE; Stoddard GJ; Tae Kim H; Sause WT; Scaife CL
    J Gastrointest Surg; 2019 Jun; 23(6):1206-1217. PubMed ID: 30421120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
    Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
    Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database.
    Simon HL; de Paula TR; Profeta da Luz MM; Kiran RP; Keller DS
    Dis Colon Rectum; 2021 Sep; 64(9):1096-1105. PubMed ID: 33951688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Caturegli I; Molin MD; Laird C; Molitoris JK; Bafford AC
    J Surg Res; 2020 Dec; 256():317-327. PubMed ID: 32712447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Neoadjuvant Treatment on the Tumor Microenvironment in Rectal Cancer: Implications for Immune Activation and Therapy Response.
    Chen CC; Wu ML; Huang KC; Huang IP; Chung YL
    Clin Colorectal Cancer; 2020 Dec; 19(4):e164-e180. PubMed ID: 32387305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
    Ruppert R; Kube R; Strassburg J; Lewin A; Baral J; Maurer CA; Sauer J; Junginger T; Hermanek P; Merkel S;
    J Am Coll Surg; 2020 Oct; 231(4):413-425.e2. PubMed ID: 32697965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital and surgeon variation in positive circumferential resection margin among rectal cancer patients.
    Justiniano CF; Aquina CT; Fleming FJ; Xu Z; Boscoe FP; Schymura MJ; Temple LK; Becerra AZ
    Am J Surg; 2019 Nov; 218(5):881-886. PubMed ID: 30853095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does one size fit all? Risks and benefits of neoadjuvant chemoradiation in patients with clinical stage IIA rectal cancer requiring abdominoperineal resection.
    de Camargo MGM; Xhaja X; Aiello A; Liska D; Gorgun E; Dietz DW; Kalady MF; Delaney CP; Steele SR; Valente MA
    Am J Surg; 2020 Mar; 219(3):406-410. PubMed ID: 31672306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
    Molinari C; Passardi A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omission of or Poor Response to Preoperative Chemoradiotherapy Impacts Radial Margin Positivity Rates in Locally Advanced Rectal Cancer.
    Ore AS; Dombek GE; Cordova-Cassia CA; Quinn JF; Cataldo TE; Schlechter BL; Abrams MJ; Messaris E
    Dis Colon Rectum; 2021 Jun; 64(6):669-676. PubMed ID: 33955406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
    Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
    Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
    Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
    Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
    Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.